Home/Filings/4/0001209191-23-018327
4//SEC Filing

THOMAS FRANK E 4

Accession 0001209191-23-018327

CIK 0001748907other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 8:30 AM ET

Size

7.3 KB

Accession

0001209191-23-018327

Insider Transaction Report

Form 4
Period: 2023-03-10
THOMAS FRANK E
See Remarks
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-10$0.46/sh+20,000$9,18292,081 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-03-1020,000335,000 total
    Exercise: $0.46Exp: 2032-05-31Ordinary Shares (20,000 underlying)
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.
  • [F2]The shares subject to this option vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.

Issuer

Orchard Therapeutics plc

CIK 0001748907

Entity typeother

Related Parties

1
  • filerCIK 0001242616

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:30 AM ET
Size
7.3 KB